LABD vs. VYM
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and VYM (Vanguard High Dividend Yield ETF) are both exchange-traded funds - LABD is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (-300%), while VYM is a Dividend fund tracking the FTSE High Dividend Yield Index. Both are passively managed. Over the past 10 years, LABD returned -56.11%/yr vs 11.90%/yr for VYM. At a correlation of -0.48, they often move in opposite directions. LABD charges 1.06%/yr vs 0.04%/yr for VYM.
Performance
LABD vs. VYM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -29.83% return, which is significantly lower than VYM's 12.47% return. Over the past 10 years, LABD has underperformed VYM with an annualized return of -56.11%, while VYM has yielded a comparatively higher 11.90% annualized return.
LABD
- 1D
- -4.73%
- 1M
- 4.70%
- YTD
- -29.83%
- 6M
- -31.22%
- 1Y
- -80.27%
- 3Y*
- -49.85%
- 5Y*
- -41.45%
- 10Y*
- -56.11%
VYM
- 1D
- -0.43%
- 1M
- 3.38%
- YTD
- 12.47%
- 6M
- 12.01%
- 1Y
- 26.16%
- 3Y*
- 18.88%
- 5Y*
- 11.48%
- 10Y*
- 11.90%
LABD vs. VYM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -29.83% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
VYM Vanguard High Dividend Yield ETF | 12.47% | 15.42% | 17.60% | 6.57% | -0.43% | 26.20% | 1.15% | 24.06% | -5.92% | 16.42% |
Correlation
The correlation between LABD and VYM is -0.42, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.42 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.49 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.47 |
Correlation (All Time) Calculated using the full available price history since May 29, 2015 | -0.48 |
The correlation between LABD and VYM has been stable across timeframes, ranging from -0.50 to -0.42 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. VYM — Risk / Return Rank
LABD
VYM
LABD vs. VYM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Vanguard High Dividend Yield ETF (VYM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | VYM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.62 | ||
| Sortino ratioReturn per unit of downside risk | -5.87 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 1.46 | -0.71 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 3.93 | -4.89 |
| Martin ratioReturn relative to average drawdown | -1.31 | 14.76 | -16.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABD | VYM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.06 | 2.56 | -3.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.43 | 0.83 | -1.26 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.59 | 0.73 | -1.32 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | 0.51 | -1.05 |
Drawdowns
LABD vs. VYM - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than VYM's maximum drawdown of -56.98%. Use the drawdown chart below to compare losses from any high point for LABD and VYM.
Loading charts...
Drawdown Indicators
| LABD | VYM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -56.98% | -43.01% |
Max Drawdown (1Y)Largest decline over 1 year | -83.21% | -6.69% | -76.52% |
Max Drawdown (3Y)Largest decline over 3 years | -95.31% | -14.46% | -80.85% |
Max Drawdown (5Y)Largest decline over 5 years | -98.24% | -15.84% | -82.40% |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | -35.21% | -64.77% |
Current DrawdownCurrent decline from peak | -99.99% | -0.43% | -99.56% |
Average DrawdownAverage peak-to-trough decline | -90.92% | -7.19% | -83.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.36% | 1.78% | +59.58% |
Volatility
LABD vs. VYM - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 27.46% compared to Vanguard High Dividend Yield ETF (VYM) at 2.77%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than VYM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | VYM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.46% | 2.77% | +24.69% |
Volatility (6M)Calculated over the trailing 6-month period | 61.67% | 7.67% | +54.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.77% | 10.28% | +65.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.26% | 13.96% | +82.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.93% | 16.34% | +79.59% |
LABD vs. VYM - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than VYM's 0.04% expense ratio.
Dividends
LABD vs. VYM - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 6.45%, more than VYM's 2.19% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 6.45% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% | 0.00% | 0.00% |
VYM Vanguard High Dividend Yield ETF | 2.19% | 2.44% | 2.74% | 3.12% | 3.01% | 2.76% | 3.18% | 3.03% | 3.40% | 2.80% | 2.91% | 3.22% |
Frequently Asked Questions
LABD and VYM have a correlation of -0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (27.46%) compared to VYM (2.77%). In terms of maximum drawdown, LABD dropped -99.99% vs VYM's -56.98%.
On 10-year performance, VYM leads with 11.90% vs -56.11% for LABD. On fees, VYM is cheaper at 0.04% per year. On volatility, VYM has been the lower-risk option at 2.77%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, VYM has performed better with a 11.90% return vs -56.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VYM is cheaper with a 0.04% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 6.45%, compared with 2.19% for VYM.
LABD is categorized as Leveraged Equities, while VYM is Dividend. LABD tracks S&P Biotechnology Select Industry Index (-300%), while VYM tracks FTSE High Dividend Yield Index. They also come from different issuers: Direxion and Vanguard. Their fees differ too: 1.06% for LABD and 0.04% for VYM.
VYM currently has the higher Sharpe Ratio (2.56 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and VYM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer